VIDAS NT-pro-BNP Product Usage: VIDAS¿ NTproBNP (PBNP) is an automated quantitative test for ...

FDA Device Recall #Z-2779-2016 — Class III — April 15, 2016

Recall Summary

Recall Number Z-2779-2016
Classification Class III — Low risk
Date Initiated April 15, 2016
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Biomerieux France Chemin De L'Or
Location Marcy L'Etoile, N/A
Product Type Devices
Quantity 229 kits

Product Description

VIDAS NT-pro-BNP Product Usage: VIDAS¿ NTproBNP (PBNP) is an automated quantitative test for use on the instruments of the VIDAS family for the determination of N terminal fragment of Btype natriuretic peptide in human serum or plasma (lithium heparin) using the ELFA technique (EnzymeLinked Fluorescent Assay). The VIDAS NTproBNP (PBNP) test is used as an aid in the diagnosis of suspected congestive heart failure.

Reason for Recall

Due to a packaging error; The kit does not contain the correct number of C1 or C2 control vials.

Distribution Pattern

US Nationwide Distribution in the states of: AL, AZ, CA, FL, GA, IA, KS, KY, MA, MI, MN, NC, NE, NJ, NY, OH, SC, TX, VA and WV.

Lot / Code Information

Reference number: 30449-01, Lot #1004474560.

Other Recalls from Biomerieux France Chemin De L'Or

Recall # Classification Product Date
Z-0843-2014 Class II API NH (REF 10400) API NH is a standardized ... Nov 8, 2013
Z-0842-2014 Class II API Listeria (REF 10300) API Listeria is a s... Nov 8, 2013
Z-0841-2014 Class II ZYM B Reagent (REF 70493) ZYM B reagent is a... Nov 8, 2013

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.